1. Home
  2. LSB vs SER Comparison

LSB vs SER Comparison

Compare LSB & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSB
  • SER
  • Stock Information
  • Founded
  • LSB 2002
  • SER 2017
  • Country
  • LSB China
  • SER United States
  • Employees
  • LSB N/A
  • SER N/A
  • Industry
  • LSB
  • SER Biotechnology: Pharmaceutical Preparations
  • Sector
  • LSB
  • SER Health Care
  • Exchange
  • LSB NYSE
  • SER Nasdaq
  • Market Cap
  • LSB 49.8M
  • SER 46.7M
  • IPO Year
  • LSB N/A
  • SER 2018
  • Fundamental
  • Price
  • LSB $2.51
  • SER $6.13
  • Analyst Decision
  • LSB
  • SER
  • Analyst Count
  • LSB 0
  • SER 0
  • Target Price
  • LSB N/A
  • SER N/A
  • AVG Volume (30 Days)
  • LSB 15.9K
  • SER 37.9K
  • Earning Date
  • LSB 01-21-2025
  • SER 11-12-2024
  • Dividend Yield
  • LSB N/A
  • SER N/A
  • EPS Growth
  • LSB N/A
  • SER N/A
  • EPS
  • LSB N/A
  • SER N/A
  • Revenue
  • LSB $79,415,311.00
  • SER $3,157,500.00
  • Revenue This Year
  • LSB $39.33
  • SER N/A
  • Revenue Next Year
  • LSB $75.61
  • SER N/A
  • P/E Ratio
  • LSB N/A
  • SER N/A
  • Revenue Growth
  • LSB N/A
  • SER 2454.55
  • 52 Week Low
  • LSB $1.88
  • SER $3.81
  • 52 Week High
  • LSB $11.20
  • SER $23.18
  • Technical
  • Relative Strength Index (RSI)
  • LSB 44.96
  • SER 58.82
  • Support Level
  • LSB $2.10
  • SER $4.15
  • Resistance Level
  • LSB $2.77
  • SER $6.24
  • Average True Range (ATR)
  • LSB 0.36
  • SER 0.73
  • MACD
  • LSB 0.01
  • SER 0.08
  • Stochastic Oscillator
  • LSB 34.68
  • SER 84.62

About LSB LAKESHORE BIOPHARMA CO LTD

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Share on Social Networks: